About Us

Biography - Timothy Wiegand, MD, FACMT, FAACT, DFASAM

WiegandTimothy-www

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM specializes in Medical Toxicology and Addiction Medicine. He is an Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service at Strong Memorial Hospital and the University of Rochester Medical Center. Dr. Wiegand is also the Medical Director for Huther Doyle, an addiction services provider in Rochester, New York, where he works in a collaborative model providing a variety of services for patients with substance use disorders, and serves as facilitator for their Project ECHO program on Pain, Opioid Prescribing and Addiction. In addition to ED, hospital and clinic work treating drug exposures, intoxication, withdrawal and assisting with pain management for patients maintained on Medications for Opioid Use Disorder (MOUD) in the ED, hospital and perioperative setting, Dr. Wiegand is involved with medical education and research in toxicology and addiction. He is the Program Director for the UR Emergency Medicine & Toxicology based Addiction Medicine Fellowship and he is core faculty for the Emergency Medicine residency at Strong Memorial Hospital. He lectures locally, regionally, nationally and internationally on topics in addiction medicine and medical toxicology and serves on the Board of Directors for both the American College of Medical Toxicology (ACMT), completing 2nd term, and is an At-Large Director for the American Society of Addiction Medicine (ASAM). He also is the President of the New York Chapter of the American Society of Addiction Medicine (NYSAM). Dr. Wiegand is particularly interested in the integration and collaboration between addiction medicine and medical toxicology. To this end he has Chaired and served on the Addiction Medicine Committee for ACMT and coordinated or participated in many presentations from toxicologists at the annual scientific meeting for ASAM as well as for his state chapter, NYSAM. He is also the Moderator for the new ACMT/ASAM Addiction and Toxicology Case Conference with emphasis on treatment of substance use disorder during COVID19 pandemic. Dr. Wiegand has been awarded the Millennium Labs Late Breaking Abstract Research Award Twice with submissions on A.) Addiction Medicine Training in Medical Toxicology Fellowship Programs and B.) The Interpretation of Buprenorphine Metabolite Levels in Urine Drug Testing. He was also the mentor and senior author to Dr. Jade Malcho whose poster: Three Cases of Buprenorphine Micro induction in Critically Ill Patients was awarded the 2020 Virtual ASAM Conference Young Investigator Award for Best Poster.

Disclosure of Interests and Affiliations